Gene-drug interactions (data source: DGIdb)
Gene Name Entrez ID Drug Name Chembl ID Interaction Types Sources publications
MAP2K2 5605 BOSUTINIB CHEMBL288441 inhibitor DrugBank 19039322
MAP2K2 5605 CI-1040 CHEMBL105442 inhibitor MyCancerGenome, ChemblInteractions
MAP2K2 5605 PD-0325901 CHEMBL507361 inhibitor TALC, MyCancerGenome, ChemblInteractions, MyCancerGenomeClinicalTrial
MAP2K2 5605 DABRAFENIB MESYLATE CHEMBL2105729 inhibitor MyCancerGenomeClinicalTrial
MAP2K2 5605 TAK-733 CHEMBL1615025 inhibitor MyCancerGenome, ClearityFoundationClinicalTrial, ChemblInteractions
MAP2K2 5605 COBIMETINIB CHEMBL2146883 inhibitor, allosteric modulator MyCancerGenome, ClearityFoundationClinicalTrial, GuideToPharmacologyInteractions, ChemblInteractions, MyCancerGenomeClinicalTrial
MAP2K2 5605 Refametinib CHEMBL2138601 inhibitor, allosteric modulator TALC, MyCancerGenome, ClearityFoundationClinicalTrial, GuideToPharmacologyInteractions, ChemblInteractions, MyCancerGenomeClinicalTrial
MAP2K2 5605 ARRY-300 CHEMBL3545359 TdgClinicalTrial
MAP2K2 5605 TRAMETINIB DIMETHYL SULFOXIDE CHEMBL2105741 inhibitor ChemblInteractions
MAP2K2 5605 RG-7167 CHEMBL3545383 inhibitor ChemblInteractions
MAP2K2 5605 TRAMETINIB CHEMBL2103875 inhibitor TALC, MyCancerGenome, ClearityFoundationClinicalTrial, GuideToPharmacologyInteractions, MyCancerGenomeClinicalTrial
MAP2K2 5605 SELUMETINIB CHEMBL1614701 inhibitor TALC, MyCancerGenome, ClearityFoundationClinicalTrial, ChemblInteractions, MyCancerGenomeClinicalTrial
MAP2K2 5605 PIMASERTIB CHEMBL2107832 inhibitor TALC, MyCancerGenome, ClearityFoundationClinicalTrial, ChemblInteractions
MAP2K2 5605 AZD-8330 CHEMBL3182621 inhibitor MyCancerGenome, ChemblInteractions
MAP2K2 5605 COBIMETINIB FUMARATE CHEMBL2364607 inhibitor ChemblInteractions
MAP2K2 5605 BALAMAPIMOD CHEMBL2104954 inhibitor ChemblInteractions
MAP2K2 5605 Ro-4987655 CHEMBL1614766 inhibitor ChemblInteractions
MAP2K2 5605 BINIMETINIB CHEMBL3187723 inhibitor, allosteric modulator MyCancerGenome, TdgClinicalTrial, ClearityFoundationClinicalTrial, GuideToPharmacologyInteractions, ChemblInteractions, MyCancerGenomeClinicalTrial
MAP2K2 5605 CHEMBL261237 CHEMBL261237 inhibitor GuideToPharmacologyInteractions
MAP2K2 5605 WX-554 CHEMBL3545145 inhibitor TdgClinicalTrial, ChemblInteractions
MAP2K2 5605 AS-703988 CHEMBL3545243 inhibitor ChemblInteractions
MAP2K2 5605 RG-7304 CHEMBL3545081 inhibitor ChemblInteractions

Variant-drug associations (data source: PharmGKB)
Gene Name Variant Alleles Chemical Phenotype Category Significance Notes Sentence Publications Annotation ID